| NCT ID | NCT04657367 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Bialystok |
| Condition | Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-02-03 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-02-03 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this project is to create a registry of diabetic patients, containing a detailed clinical profile of each patient, along with omics data, which will be analyzed using artificial intelligence algorithms, and their results will be implemented in the form of new recommendations of care for high-risk patients and those already suffering from diabetes. The study will be conducted prospectively. The project participants will be patients with diabetes, patients at high risk of developing diabetes and a control group of normoglycemic patients who will participate in study visits at the Clinical Research Center of the Medical University of Bialystok.
Eligibility Criteria
Inclusion Criteria: * patients with diagnosed diabetes (according to the American Diabetes Association criteria) - diabetes group * patients with diagnosed prediabetes (IFG and/or IGT) - prediabetes group * patients with normoglycemia (NFG and NGT) - normoglycemia group * informed consent Exclusion Criteria: * drug addiction * severe psychiatric disorders * patients with gestational diabetes mellitus * patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04657367 clinical trial?
This trial is open to participants of all sexes, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04657367 currently recruiting?
Yes, NCT04657367 is actively recruiting participants. Contact the research team at lukasz.szczerbinski@umb.edu.pl for enrollment information.
Where is the NCT04657367 trial being conducted?
This trial is being conducted at Bialystok, Poland.
Who is sponsoring the NCT04657367 clinical trial?
NCT04657367 is sponsored by Medical University of Bialystok. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.